Stay updated on AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page history now includes Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a new revision (v3.3.2) and removed an older revision (v3.2.0) from the Study Record Versions list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe banner about government funding and operations has been removed from the page, and the study information remains unchanged.SummaryDifference0.7%

- Check61 days agoChange DetectedThe core historical data and version history remain unchanged; only minor UI/layout differences are visible between the old and new screenshots.SummaryDifference0.1%

- Check83 days agoChange DetectedUpdated version to v3.2.0 and added a government-status notice; removed the previous v3.1.0 reference.SummaryDifference13%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page.